Radio(chemo)therapy does differently impact on PD-L1 and PD-L2 expression in human melanoma cell lines (2018) Derer A, Riegel D, Frey B, Fietkau R, Gaipl U Conference contribution Pretreatment vitamin D levels are associated with improved overall survival following combined chemoradiotherapy (2018) Putz F, Distel L, Lettmaier S, Weissmann T, Filimonova I, Fietkau R Conference contribution Mechanism of necrotic Cell Clearance by non-professional Phagocytes (2018) Hofmann A, Seeberg J, Fietkau R, Distel L Conference contribution Proliferating non-professional Phagocytes are able to generate Cell-in-Cell Structures (2018) Hofmann A, Seeberg J, Fietkau R, Distel L Conference contribution Kinase Inhibitor Palbociclib shows differential Effects upon Irradiation on Normal Tissue and Cancer Cell Lines (2018) Jost T, Proebstle S, Buerkel F, Hecht M, Fietkau R, Distel L Conference contribution Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment (2018) Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article Quality Assurance by electromagnetic Tracking in Interstitial multi-catheter HDR Brachytherapy Using a hybrid Afterloading System (2018) Kallis K, Strnad V, Fietkau R, Bert C Conference contribution Retrospective inconsistent analysis cannot validate safety of a treatment strategy (2018) Strnad V Journal article Immune suppressive properties of Glioblastoma cells might result in part from radiation-induced increased expression of inhibitory immune checkpoint molecules (2018) Langenfelder E, Derer A, Fietkau R, Gaipl U, Frey B Conference contribution Influence of radiotherapy-induced reactive oxygen species on the immunogenic potential of HPV plus in comparison to HPV-HNSCC (2018) Peitz L, Frey B, Rieckmann T, Fietkau R, Gaipl U Conference contribution